Liver-targeting drugs and their effect on blood glucose and hepatic lipids Amalia GastaldelliNorbert StefanHans-Ulrich Häring Review Open access 20 April 2021 Pages: 1461 - 1479
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis Sabrina SchlesingerManuela NeuenschwanderMichael Roden Article Open access 28 April 2021 Pages: 1480 - 1491
Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis Marianne BennFrida EmanuelssonBørge G. Nordestgaard Article 25 March 2021 Pages: 1492 - 1503
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease Lili ChanGirish N. NadkarniScott M. Damrauer Article Open access 02 April 2021 Pages: 1504 - 1515
Postpartum circulating microRNA enhances prediction of future type 2 diabetes in women with previous gestational diabetes Mugdha V. JoglekarWilson K. M. WongMartha Lappas Article 23 March 2021 Pages: 1516 - 1526
Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes? Siobhan BaconDylan Burgeron behalf of the CONCEPTT Collaborative Group Article 10 April 2021 Pages: 1527 - 1537
Diabetes-related lower extremity complications in a multi-ethnic Asian population: a 10 year observational study in Singapore Tessa RiandiniDeanette PangKavita Venkataraman Article Open access 22 April 2021 Pages: 1538 - 1549
Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study Joline W. J. BeulensJosan S. YauwAmber A. van der Heijden Article Open access 27 April 2021 Pages: 1550 - 1562
Sodium–glucose cotransporter 2 inhibitors and risk of nephrolithiasis Kasper B. KristensenDaniel P. HenriksenLars C. Lund Article 13 March 2021 Pages: 1563 - 1571
Vitamin D concentrations from neonatal dried blood spots and the risk of early-onset type 2 diabetes in the Danish D-tect case-cohort study Amélie KellerFanney ThorsteinsdottirBerit L. Heitmann Article 24 May 2021 Pages: 1572 - 1582
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes Matthew W. SegarKershaw V. PatelAmbarish Pandey Article 13 March 2021 Pages: 1583 - 1594
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls David NathansonAnn-Marie SvenssonKatarina Eeg-Olofsson Article Open access 27 March 2021 Pages: 1595 - 1603
Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes Randi K. JohnsonRoy Tamurafor the TEDDY Study Group Article 30 March 2021 Pages: 1604 - 1612
Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose Ren-Hua ChungYen-Feng ChiuChao A. Hsiung Article 12 April 2021 Pages: 1613 - 1625
Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes Éva KorposNadir KadriLydia Sorokin Article Open access 29 April 2021 Pages: 1626 - 1641
Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity Amy E. MendhamJulia H. GoedeckeElin Chorell Article Open access 26 March 2021 Pages: 1642 - 1659
Oestrogen receptor α in T cells controls the T cell immune profile and glucose metabolism in mouse models of gestational diabetes mellitus Tomoko TanakaTsutomu WadaToshiyasu Sasaoka Article 01 April 2021 Pages: 1660 - 1673
Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction Sandra S. HammerCristiano P. VieiraJulia V. Busik Article 26 March 2021 Pages: 1674 - 1689
IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes Abigail C. LayLorna J. HaleRichard J. M. Coward Article Open access 24 March 2021 Pages: 1690 - 1702
Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation Dario IafuscoAngela ZanfardinoFabrizio Barbetti Research Letter Open access 14 May 2021 Pages: 1703 - 1706